Drug Profile
Prezatide copper acetate
Alternative Names: GHK-Cu; GraftCyte; Iamin; Iamin-1B; Iamin® gel; KPC 1193; Neova; PC 1020Latest Information Update: 12 Nov 2008
Price :
$50
*
At a glance
- Originator ProCyte Corporation
- Class Antihyperglycaemics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Burns; Chronic wounds; Skin ulcer
- Discontinued Diabetic foot ulcer; Inflammatory bowel diseases; Ulcerative colitis; Wounds
Most Recent Events
- 12 Nov 2008 Typo fixed
- 12 May 2005 ProCyte Corporation has been acquired by PhotoMedex
- 18 Nov 2003 Discontinued - Phase-II for Inflammatory bowel disease in USA (Rectal)